Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences
Conditions: Metastatic Melanoma; Metastatic Malignant Neoplasm in the Chest Wall; Recurrent Breast Carcinoma Interventions: Drug: Olaparib; Procedure: Hyperthermia Treatment; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Thomas Jefferson University; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Melanoma | Research | Skin Cancer